Melanoma/Skin Cancer

Top Story

Monthly cost of oral cancer drugs rises steadily over time

Monthly cost of oral cancer drugs rises steadily over time
April 28, 2016

The cost of oral cancer drugs in their first year on the market has increased significantly since the year 2000, according to a research letter published in JAMA Oncology.

High drug prices can affect patient adherence to cancer therapies and increase the financial burden of medical care, according to Stacie B. Dusetzina, PhD, assistant professor of pharmaceutical outcomes and policy at University of North Carolina Eshelman School of Pharmacy.

In the Journals

Cancer diagnosis increases risk for mental disorders, psychiatric medication use

April 28, 2016
Patients diagnosed with cancer faced an increased risk for common mental disorders — such as depression, anxiety and stress reaction/adjustment disorder —…
In the Journals

Rapid lump examination shows promise in speeding up Mohs micrographic surgery

April 26, 2016
Rapid lump examination enabled fast detection of residual basal cell carcinoma during Mohs micrographic surgery, according to published study results.Researchers…
FDA News

FDA grants breakthrough designation to Opdivo for SCCHN

April 25, 2016
The FDA granted breakthrough therapy designation to nivolumab for the treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck who…
CME

Updates in Melanoma 2015: Entering a New Therapeutic Era

This activity is supported by an educational grant from Merck & Co., Inc.

The incidence of melanoma, an aggressive disease that accounts for approximately 75% of skin-cancer-related deaths, is…
More »
Video
Meeting News Coverage

VIDEO: Speaker outlines challenges of biomarker development

March 31, 2016
More »
Featured
At Issue: Multiple Myeloma Resource Center

At Issue: Multiple Myeloma Resource Center

CME

The Patient with Lymphadenopathy

No commercial support for this activity.

Castleman’s disease is a rare lymphoproliferative disorder that is characterized by enlargement of 1 (unicentric) or…
More »
In the Journals

Monthly cost of oral cancer drugs rises steadily over time

April 28, 2016
The cost of oral cancer drugs in their first year on the market has increased significantly since the year 2000, according to a research letter…
In the Journals

Cancer diagnosis increases risk for mental disorders, psychiatric medication use

April 28, 2016
Patients diagnosed with cancer faced an increased risk for common mental disorders — such as depression, anxiety and stress reaction/adjustment…
In the Journals

Rapid lump examination shows promise in speeding up Mohs micrographic surgery

April 26, 2016
Rapid lump examination enabled fast detection of residual basal cell carcinoma during Mohs micrographic surgery, according to published study…
FDA News

FDA grants breakthrough designation to Opdivo for SCCHN

April 25, 2016
The FDA granted breakthrough therapy designation to nivolumab for the treatment of patients with recurrent or metastatic squamous cell carcinoma of…
Meeting News Coverage

BGB-283 effective against tumors with BRAF, RAS mutations

April 24, 2016
NEW ORLEANS — An investigational agent designed to target the RAF family of proteins demonstrated clinical activity in patients with cancer who…
Meeting News Coverage

Eight important updates from the AACR Annual Meeting

April 22, 2016
The American Association for Cancer Research Annual Meeting, held April 16-20 in New Orleans, featured the theme “Delivering Cures Through…
In the Journals

Pooled analysis confirms clinical benefit of pembrolizumab for advanced melanoma

April 21, 2016
Pembrolizumab demonstrated favorable long-term safety and antitumor activity in patients with advanced-stage melanoma, according to a pooled analysis…
Meeting News Coverage

Biden: Realignment of research incentives key to cancer moonshot initiative

April 20, 2016
A redesign of the cancer research enterprise is necessary to accelerate advances and achieve 10 years’ worth of progress in 5 years, Vice…
In the Journals

Risk factors identified for skin cancer mortality after organ transplant

April 20, 2016
Older patients, male patients and thoracic transplant recipients were at increased risk for mortality from skin cancer following organ…
Meeting News CoveragePerspective

Pembrolizumab induces durable responses in advanced Merkel cell carcinoma

April 19, 2016
NEW ORLEANS — First-line systemic therapy with the anti–PD-1 antibody pembrolizumab induced a high response rate in patients with…
More Headlines »
morganatic-roan